Analysis of clinical trials with biologics using dose-time-response models.

about

Impact of mathematical pharmacology on practice and theory: four case studies.

P2860

Q47694906-008F4CD7-911A-4DBE-AEF2-911E4EFD0AEC

P2860

Analysis of clinical trials with biologics using dose-time-response models.

Item

http://www.wikidata.org/entity/Q40852651

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Analysis of clinical trials with biologics using dose-time-response models.

@en

type

Item

label

Analysis of clinical trials with biologics using dose-time-response models.

@en

prefLabel

Analysis of clinical trials with biologics using dose-time-response models.

@en

P1476

Analysis of clinical trials with biologics using dose-time-response models.

@en

P2093

Markus R Lange

http://www.w3.org/2001/XMLSchema#string

P2860

Modeling of dose-response-time data: four examples of estimating the turnover parameters and generating kinetic functions from response profiles.

Dose-response-time data analysis involving nonlinear dynamics, feedback and delay.

Semiparametric analysis of non-steady-state pharmacodynamic data.

A latent pharmacokinetic time profile to model dose-response survival data.

Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Drug treatment effects on disease progression.

Development trends for human monoclonal antibody therapeutics.

Use of canakinumab in the cryopyrin-associated periodic syndrome.

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.

A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.

P304

3017-3028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SIM.6551

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heinz Schmidli

P577

2015-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26059422

http://www.w3.org/2001/XMLSchema#string

Analysis of clinical trials with biologics using dose-time-response models.

about

P2860

P2860

Analysis of clinical trials with biologics using dose-time-response models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698